FDA Calendar
Upcoming clinical readouts, trial starts, and trial-progress milestones for U.S.-listed biotech, with official source links.
FREE BETA · Guests can view 30 days, including today (through Nov 10, 2026, ET). Sign in for the full calendar.
1 of 1,611 scheduled catalysts · 1 of 429 companies with matching events
Evidence: A regulator/SEC/trial registry · B official company source · Market data is separate context.
Scheduled catalysts
Scroll the table horizontally to view all columns →
Next CatalystCompanyDrugPrice · 30DCurrent stage
COMPASS THERAPEUTICS, INC.CMPX
DrugCTX-009bispecific antibody
Indicationsecond-line unresectable advanced, metastatic or recurrent biliary tract cancerCOMPANION-002 · previously treated patients with advanced biliary tract cancer
TargetDLL4 / VEGF-A
Clinical dataPhase 2/3 dataOct 24, 2026ESMO Congress
COMPANION-002 · will highlight the results of the randomized, controlled Phase 2/3 COMPANION-002 clinical trial
BOfficial sourceCurrent stage
PreINDP1P2P3FilingApproved
Price · 30D
$1.05-49.0%
30D · 10/09